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IN 1935 Mcfarlane demonstrated, in the sera of a patient suffering from
myelomatosis, a protein having an unusual sedimentation constant. It has been
shown that these sedimentation constants vary according to the protein concen-
tration at which they are estimated (Neurath and Bailey, 1953). If there is not
gross asymmetry of the molecule examined, and this is the case for most serum
proteins, the observed sedimentation is a linear function of concentration, and
the sedimentation constant obtained by extrapolation to zero concentration is
related to the observed sedimentation constant by the simple equation:-
S0°20o
= S20 +- kc
S20 being the observed sedimentation constant
°20 the sedimentation constant extrapolated to zero
c the concentration of protein in grams per 100 ml. at which the observa-
tion was made.
Koenig and Pederson (1950) have obtained K values of 0-65 and 0.25 for
fibrinogen and gamma globulin respectively. While Taylor (1952) obtained a K
value of 0.235 for albumin. It will be seen that fibrinogen, the molecule with the
highest degree of asymmetry, has the highest K value.
McConnell and Martin (1958), in the course of a physicochemical study of
globulins isolated from individual patients suffering from myelomatosis, produced
data on the relation ofsedimentation to the concentration ofthe isolated products.
Studies on isolated globulins have continued in this laboratory. Fig. 1 shows some
of this accumulated data in condensed form.
When the K values of these proteins are plotted against their electrophoretic
mobility, the appearance of the graphical results (Fig. 2) indicated that increasing
asymmetry is associated with increasing negative net charge. These demonstrable
physicochemical changes point to overall changes in the configuration of the
globulin molecule, but they do not point to precisely defined groups of globulins
so much as a spectrum of molecules with a gradation of change.
The careful studies of Wallenius, Trautmann, Kunkel and Franklin (1957)
indicated that there were several components present in normal human serum
with sedimentation coefficients other than those commonly observed in routine
ultracentrifugal analysis.
Putnam and Udin (1953) suggested that the range and frequency of myeloma
globulins in general correspond with those of normal gamma globulin. There
has therefore always been the possibility that the relatively easily identified
abnormal" proteins observed in myelomatosis might represent the abnormal
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production of proteins present, in trace amounts, in normal sera, a possibility
considered by Slater, Ward and Kunkel (1955).
If, as some writers have maintained, these myeloma globulins are inherently
different from normally produced gamma globulins, it is important to know to
what extent and in what way they differ. To extend the study ofthese globulins
it was thought that the immunoelectrophoretic technique ofWilliams and Grabar,
modified for microanalysis by Scheidigger (1955), might yield useful information.
Seow
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FIG. 1.-Sedimentation concentration ratio
* 0 normal gamma globulin
O O myeloma gamma globulins
Each line represents the plot of the slope calculated from not less than five individual
measurements.
MATERIAL AND METHODS
In these investigations fresh serum from fasting patients, in whom a diagnosis
of myelomatosis had been established both on clinical and histological grounds,
was used. Electrophoretic analyses were made in the Tiselius apparatus using
0.2 M phosphate buffer at pH 8.0 at 0°C. Ancillary electrophoretic investigations,
when the material was insufficient for the classical technique, were made on paper
by the method described by Franglen, Martin and Treherne (1955). Immuno-
710MYELOMA GLOBULINS
electrophoretic analyses were madebythemicrotechnique describedbyScheidigger
(1955), and nitrogen estimations were done by the Micro-Kjeldahl method.
Preparation ofantisera
Antisera were prepared in rabbits by two methods:
(1) Intramuscular injection of a suspension of an alumina precipitate of the
antigenic protein, according to the method of Proom (1943) as used by Weitz
(1952).
Six injections of 10 ml. of the suspension in a divided dose were given at ten
day intervals. The titre started to rise after the second injection and had reached
a satisfactory level after the fifth injection.
(2) Subcutaneous inoculationoftheantigenicproteinusingFreunde'sadjuvant.
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FIG. 2.-Electrophoretic mobility ofnormal and myeloma globulins plotted against K values
derived from concentration sedimentation studies.
* normal globulin
O myeloma globulins
The following antisera were used in these investigations:
(1) Antisera against the freshly drawn serum of two patients known to be
suffering from myelomatosis, designated G and K, and showing anomalous protein
patterns in the beta and gamma areas respectively.
(2) Antisera prepared against the G4 fraction ofpooled normal sera containing
99 per cent gamma globulin.
Though theoriginal G4globulinused fortheproduction ofantibodies contained
no fast moving globulins demonstrable by classical electrophoretic analysis,
immunochemical analysis against normal sera suggested the presence of a trace
of globulin having the mobility of alpha globulin (see Fig. 4, third column).
RESULTS
Table I shows the total serum proteins and the alpha, beta and gamma glo-
bulin content of the five sera subjected to immunochemical analysis. These
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values were obtained by electrophoretic analysis in the classical Tiselius apparatus.
Representative Schlieren patterns are shown in Fig. 3.
The immunoelectrophoretic analyses against the three specific antisera are
shown in Fig. 4. Serial dilution studies of these proteins against the antisera did
nothingmore than emphasize the constant characteristics of the patterns obtained.
Serum 'W' Serum 'G'
Fic(. 3. Photographs of Tiselius' analysis of serum " W " and serum
" G " at 21 and 3 hourls.
Analysis of a 2 g./100 mnl. protein solution inI 0-2 miolar phosphate huffer at pH 8-0. at )'C.
lland at a potential graidient of iv/cm.
TABLE I.-Serum Proteins and the Alpha, Beta and Gammna Content of the
Five Sera Subjected to Immunochemical Analysis.
Patient Total protein
g/100 Inl.
WT"
I . 8 1 0
' R " 8. (;
" T " . 8.0}
"G" . 78X
" G" . 9-.9 (
0/ Total of components
(globulins)
Alb. r ^
alpha beta ganmma1 gamma2
14. 5 7 73
18 5 8 67
20 4 6 60( 9
28 7 57 7
21 8 63 7
DISCUSSION
The physicochemical data referred to in the introduction suggest a progressive
deviation in the structure of the myeloma from the normal globulins rather than
a clear cut differentiation. Thirteen out ofnineteen end group analyses ofmyeloma
globulins listed by Putnam (1956) showed aspartyl or glutamyl or both to be
present. These are the end groups commonly found in analysis ofgamma globulin.
The carbohydrate analysis ofMuiller-Eberhard and Kunkel (1956) and ofMcConnell
and Martin (1958) showedvariations in content fromvalues within the normal range
to values more than ten times the upper limit ofthe normal range.
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Differentiations based on immunological studies stem back to the work of
Bayne-Jones and Wilson (1922) and Robinson (1927). The earliest workers in the
field concluded that the myeloma proteins were not a single entity but a group
differing one from another. This has been largely confirmed by more recent work
by Wuhrmann, Wunderley and Hassig (1950), who stressed the individual
specificity of the myeloma globulins, more particularly those having mobilities of
the same order as beta globulins. Later work by Slater, Ward and Kunkel (1955),
Globulin Globulin
'normal'
'W'
normal'
IC,
anti- G anti-K anti -normal -y
FIG. 4.-Tracing of immunoelectrophoretic analysis of sera"W,"" R,"" T,"" G," and "C.'
The black dots represent the wells in which 0.001 ml. serum dilution,. equivalent to 5 g./100
ml. of protein were placed. The electrophoretic analyses were carried out at 15 volts across
each slide for four hours in glycine buffer, 0.05 ionic strength, with 2 per cent agar as support
medium. At the completion ofthe electrophoretic analyses, the specific antisera were allowed
to diffuse out through the agar from saturated strips of filter paper, placed centrally on the
slide in its long axis.
employing precipitin techniques and the diffusion technique of Ouchterlony,
showed, among other features, that "the gamma type of myeloma proteins were
all related to normal gamma globulins or a fraction thereof. . . "while there was
".. a definite but distant relationship between the beta myeloma proteins and
normal gamma globulin."
In so far as they are comparable, the immunoelectrophoretic studies presented
in this paper confirm this view, suggesting that antigenic sites of the myeloma
globuli have much in common with normal gamma globulin.
The recent work on rabbit gamma globulin by Porter (1959) seems to show
that antigenic activity is confined to onefragment ofthewhole molecule comprising
approximately 45 per cent ofthe whole unit. Ifthe antigenic sites ofhumangamma
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globulin are concentrated in the same way, it is not difficult to collate the physico-
chemical differences with the immunological similarities in this complex group of
proteins.
The production of a " biologically" satisfactory protein takes place in three
phases, the assemblage of aminoacids and their linkage through the usual con-
densation of the terminal carboxyl of the one with the alpha amino with adjacent
member in the series, the total or partial coiling ofthe chain so formed into a helix
and the final folding of this helix; the second and third phases being associated
with cross-bonding giving S--S bridging, and other forms of cross-linkage of
a less well-defined and perhaps less stable character. The effect of this folding is
to determine the number ofreactive groups on the outward surface ofthe molecule
and their relationship one to another. Specific antigen and antibody reactions
are determined by the "pattern" of these groups and their accessibility.
In the present examinations the antibody reaction with the globulins in the
individual myeloma sera was constant, whether the antibody was produced to the
specific globulins ofthat patient, or to globulins from other patients, or to globulins
from normal people. It would seem then that, if this reaction is related to surface
pattern" on individual molecules or groups of molecules, these patterns are
present in the globulins in normal patients as well as those suffering from myelo-
matosis, the essential difference being the frequency with which one pattern
recurs, that is a quantitative rather than a qualitative difference.
In the hundred cases of myelomatosis we have examined, we have never
obtained any evidence of a hereditary defect suggesting a genetic origin. Nor, so
far, have we any evidence of internal variations of aminoacid sequences peculiar
to one or any of the myeloma proteins. Many of the demonstrated differences in
shape, in charge, and in predominance of a given immunological pattern, may be
explicable in terms of a defect ofthe final folding ofthe chain rather than in varia-
tions in the aminoacid sequence similar to those demonstrated in the haemoglobins.
It is possible these changes depend on the ratio within the molecule of a helical
to non-helical configuration and this possibility is being tested.
SUMMARY
(1) Abnormal globulins of varying mobilities have been examined from five
patients afflicted by myelomatosis.
(2) The ultracentrifugal and immunochemical analyses suggest that these
globulins show a progressive deviation from the normal rather than falling into
well defined groups. The cause of this deviation is discussed.
Our thanks are due to the British Empire Cancer Campaign who defrayed the
cost of this work.
REFERENCES
BAYNE-JONES, S. AND WILsON, D. W.-(1922) Johns Hopk. Hosp. Bull., 33, 119
FRANGLEN, G. T., MARTIN, N. H. AND TREHERNE, J. D.-(1955) J. clin. Path., 8, 144.
KOENIG, V. L. AND PEDERSON, K. O.-(1950) Arch. Biochem., 25, 97.
MCCONNELL, R. J. AND MARTIN, N. H.-(1958) Brit. J. Cancer, 12, 264.
MCFARLANE, A. A.-(1935) Biochem. J., 29, 1175.
MMULLER-EBERHARD, F. AND KITNKEL, H. G.-(1956) J. exp. Med., 104, 253.MYELOMA GLOBULINS 715
NEURATH, H. AND BAILEY, K.-(1953) 'The Proteins,' Vol. 1, Section B. New York
(Academic Press), p. 659.
PORTER, R. R.-(1959) Biochem. J., 73, 119.
PROOM, H.-(1943) J. Path. Bact., 55, 419.
PUTNAM, F. W. (1956) J. cell. comp. Physiol., 47, 17, Suppl. i.
Idem AND UDIN, B.-(1953) J. biol. Chem., 202, 747.
ROBINSON, A. (1927) Brit. J. exp. Path., 8, 454.
SCHEIDIGGER, J. J.-(1955) Int. Arch. Allergy, N. Y., 7, 103.
SLATER, R. J., WARD, S. M. AND KUNKEL, H. G.-(1955) J. exp. Med., 101, 85.
TAYLOR, J. F.-(1952) Arch. Biochem. Biophys., 36, 357.
WALLENIUS, G., TRAUTMANN, R., KUINKEL, H. G. AND FRANKLIN, E. C.-(1957) J. biol.
Chem., 225, 253.
WEITZ, B.-(1952) J. Hyg., 50, 275.
WUHRMANN, F. H., WITNDERLY, C. L. AND HASSIG, A.-(1950) Brit. J. exp. Path., 31,
507.